OMIA:001001-9796 : Thrombocytopenia in Equus caballus (horse) |
In other species: crab-eating macaque , dog , domestic cat , pig , taurine cattle
Categories: Haematopoietic system phene
Links to possible relevant human trait(s) and/or gene(s) in OMIM: 155100 (trait) , 141000 (trait) , 188000 (trait) , 188020 (trait) , 188025 (trait) , 188030 (trait) , 273900 (trait) , 274000 (trait) , 313900 (trait) , 613112 (trait)
Mendelian trait/disorder: unknown
Disease-related: yes
Cross-species summary: Thrombocytopenia refers a platelet concentration below the reference range, non-genetic causes exist. For some species the entry includes macrothrombocytopenia
Breeds:
American Trotter (Horse) (VBO_0000899),
Quarter Horse (Horse) (VBO_0001057).
Breeds in which the phene has been documented. (If a likely causal variant has been documented for the phene, see the variant table breeds in which the variant has been reported).
Cite this entry
Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2024). OMIA:001001-9796: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70
References
Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.
2024 | Magdesian, K.G. : |
Alloimmune conditions in the neonatal foal. Vet Clin North Am Equine Pract 40:S0749-0739(24)00034-8:189-206, 2024. Pubmed reference: 38852013. DOI: 10.1016/j.cveq.2024.05.001. | |
1997 | Buechnermaxwell, V., Scott, M.A., Godber, L., Kristensen, A. : |
Neonatal alloimmune thrombocytopenia in a quarter horse foal Journal of Veterinary Internal Medicine 11:304-308, 1997. Pubmed reference: 9348499. | |
1996 | Sellon, D.C., Levine, J., Millikin, E., Palmer, K., Grindem, C., Covington, P. : |
Thrombocytopenia in horses - 35 cases (1989-1994) Journal of Veterinary Internal Medicine 10:127-132, 1996. Pubmed reference: 8743211. |
Edit History
- Created by Frank Nicholas on 06 Sep 2005
- Changed by Imke Tammen2 on 16 Jun 2024